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Abstract  
Objectives 
Despite a rising clinical and research profile, there is limited information about how frailty and 
sarcopenia are diagnosed and managed in clinical practice. Our objective was to build a picture 
of current practice by conducting a survey of UK healthcare professionals. 
Methods 
We surveyed healthcare professionals in NHS organisations, using a series of four 
questionnaires. These focussed on the diagnosis and management of sarcopenia, and the 
diagnosis and management of frailty in acute medical units, community settings and surgical 
units. 
Results 
Response rates ranged from 49/177 (28%) organisations for the sarcopenia questionnaire to 
104/177 (59%) for the surgical unit questionnaire. Less than half of responding organisations 
identified sarcopenia; few made the diagnosis using a recognised algorithm or offered resistance 
training. The commonest tools used to identify frailty were the Rockwood Clinical Frailty Scale 
or presence of a frailty syndrome. Comprehensive Geriatric Assessment was offered by the 
majority of organisations, but this included exercise therapy in less than half of cases, and 
medication review in only one-third to two-thirds of cases. 
Conclusions 
Opportunities exist to improve consistency of diagnosis and delivery of evidence-based 
interventions for both sarcopenia and frailty.  
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Introduction 
Sarcopenia and frailty have emerged as important syndromes affecting older people.1,2 Both 
conditions are associated with multiple adverse outcomes, including falls, hospitalisation and 
longer length of hospital stay, impaired ability to live independently, an increased need for care, 
and earlier death.3,4 As a result, both syndromes are now attracting attention as research topics and 
as important targets for diagnosis and management in clinical practice – not just within the 
discipline of geriatric medicine, but in other areas of clinical practice including cardiology and 
oncology.5,6 
 
As is often the case with rapidly evolving fields of clinical and research activity, several different 
tools and algorithms have been proposed for the diagnosis of both sarcopenia and frailty.7-10 For 
both conditions, an emerging evidence base supports a limited range of interventions – resistance 
training has been shown to be effective in ameliorating sarcopenia;11 outcomes for frail individuals 
are likely to be improved by the application of the process of Comprehensive Geriatric Assessment 
(CGA), based on extrapolation from the existing evidence base for CGA.12 In addition, exercise 
training may be able to prevent or improve frailty.13,14 
 
A key challenge in improving outcomes for older people with sarcopenia or frailty is to ensure that 
research findings are translated into clinical practice. Conversely, programmes of research need to 
be designed and delivered in ways that fit with the existing landscape of clinical practice; failure 
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to do so leads to difficulties in conducting research and implementing findings. A first step in this 
process is to build a picture of current practice – do organisations search for older people with 
sarcopenia or frailty, what tools are used to make the diagnosis, and what treatments and strategies 
of care are used to manage these conditions? To date, there is limited information on this topic in 
either a UK context or a European context;15 this lack of information hampers the research process, 
and the development of a consistent approach or guidance for practice. The aim of the work 
described in this paper was to survey UK healthcare professionals to understand how sarcopenia 
and frailty are diagnosed and managed in current UK practice. 
 
Materials and Methods 
We designed a series of four questionnaires focussing on: a) the diagnosis and management of 
sarcopenia; b) the diagnosis and management of frailty in acute medical units (AMUs)/frailty units; 
c) the diagnosis and management of frailty in orthopaedic and surgical services; and d) the 
diagnosis and management of frailty in community settings. We used the online survey tool 
SurveyMonkey (www.surveymonkey.com) to create the questionnaires and generated a unique 
link for each of the four questionnaires. These were then released in four waves, over the course 
of four months. During each wave the questionnaire was circulated to members of the British 
Geriatrics Society Sarcopenia and Frailty Research Special Interest Group (SiG) through British 
Geriatrics Society (BGS) media channels. In addition, the surgical questionnaire (questionnaire c) 
was circulated to the BGS Falls and Bone Health SiG and the community questionnaire 
(questionnaire d) was circulated to the BGS Community Geriatrics SiG. The questionnaires were 
also promoted using social media, with no limitations on who could participate. 
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The sarcopenia element (questionnaire a) included questions on the identification of sarcopenia, 
the diagnostic criteria used, and the interventions offered to those found to have sarcopenia, with 
a maximum of 10 questions to be answered in this questionnaire. The frailty questionnaires 
focussed on the tools used to identify frailty, the professionals involved in identifying frailty, and 
the interventions offered to those found to have frailty. There were a maximum of 43 questions to 
be answered over the three frailty questionnaires (questionnaires b, c and d; 21 questions on acute 
medical units/frailty units, 12 questions on orthopaedic and surgical services, 10 questions on 
primary care and community services). Each questionnaire was designed to take no longer than 3 
minutes to answer. Respondents were questioned on current practice within their organisation, 
rather than at the individual level. 
 
Raw data from SurveyMonkey were downloaded as Microsoft Excel files and analysed using SPSS 
v22 (IBM, New York, USA). For each questionnaire, responses were analysed at the level of the 
responding organisation. Non-UK institutions were excluded from analysis. Where more than one 
response was received from an organisation, responses were combined and a liberal approach to 
responses was adopted – e.g. if one respondent said that a tool was used to diagnose frailty, and 
another respondent said that the tool was not used, we recorded this as ‘tool used’. Descriptive 
statistics were generated for each questionnaire. 
 
Results 
Sarcopenia diagnosis and management: 
Sixty-one people completed the sarcopenia questionnaire (22 consultant geriatricians, 2 general 
practitioners (GPs), 3 trainee geriatricians, 7 specialist nurses, 13 Allied Health Professionals 
(AHPs) and 14 others), representing 49 organisations from a total of 177 hospital-based NHS 
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organisations or health boards in the UK (28%).16 26/49 (53%) reported that their organisation 
identified sarcopenia; 23/49 (47%) in inpatients, 22/49 (45%) in outpatients. 
 
19/26 (73%) of organisations who identified sarcopenia reported using any tools to do so; the tools 
used are shown in Table 1. Two organisations reported using the European Working Group on 
Sarcopenia in Older People (EWGSOP) diagnostic criteria,17 one reported using the Foundation 
for the National Institutes of Health (FNIH) criteria,18 and 16/19 (84%) reported not using a 
diagnostic algorithm for sarcopenia. Only one organisation out of the 16 responding, included and 
coded sarcopenia as a diagnosis on clinic letters or discharge summaries. 
 
Resistance training was offered to those with sarcopenia by 9/19 (47%) of organisations; 15/19 
(79%) offered functional exercise training, and 3/19 (16%) offered other types of exercise training. 
11/19 (58%) offered vitamin D, 5/19 (26%) offered protein supplementation, and 5/19 (26%) 
offered other nutritional interventions. 2/19 (11%) offered drug interventions, although these were 
not specified. 
 
Frailty diagnosis and management 
There were 98 responses to the AMU questionnaire, representing 71 organisations (40% of 177 
possible); 178 responses to the surgical and orthopaedic questionnaire, representing 104 
organisations (59% of 177 possible), and 117 responses to the community questionnaire, 
representing 80 organisations (of 194 possible when community NHS trust organisations are 
included; 41%). The professions of respondents for each questionnaire are given in Supplementary 
Table 1. 45/50 (90%) of respondent organisations using an integrated AMU model reported 
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identifying people with frailty on the AMU; 16/17 (94%) of organisations running a dedicated 
AMU for older people did so, and 10/17 (59%) of organisations running an AMU for younger 
people did so. 77/104 (74%) of organisations reported identifying people with frailty on 
orthopaedic wards. 41/90 (46%) of organisations reported identifying people with frailty on non-
orthopaedic surgical wards. 
 
At the time of the community questionnaire, targets for identification of people living with frailty 
had been introduced in England, but not in the devolved nations of Scotland, Wales or Northern 
Ireland. In England, 45/63 (71%) of organisations reported that their unit identified frailty as part 
of community team work; this was true for 14/17 (82%) of respondent organisations in the 
devolved nations. 
 
A wide variety of tools were reported as being in use for case-finding across the different areas of 
clinical activity (Table 2). The Rockwood Clinical Frailty Scale (CFS)19 was commonly used, as 
was the presence of a frailty syndrome (falls, delirium, incontinence or immobility).8 In 
community settings, the timed up and go test20 and the electronic Frailty Index21 were also 
commonly used. Case finding was performed by a wide range of staff, with multiple professions 
involved in case finding in most organisations (Table 3). In the community questionnaire, GPs 
were the commonest professional group undertaking case finding (33/80 organisations) followed 
by specialist nurses (29/80), geriatricians (22/80), AHPs (17/80), district nurses (11/80) and 
practice nurses (10/80). A variety of other professional groups also identified frailty, including 
social workers, paramedics, mental health professionals and care coordinators. 
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Figure 1 depicts interventions offered to patients with frailty. Although CGA was offered to a 
majority of patients, key components of CGA were offered less often; medication reviews were 
offered by only a third to two-thirds of units, and exercise or physiotherapy programmes by less 
than half of units. In the community questionnaire, geriatricians and non-geriatricians gave similar 
responses to the type of interventions offered, with the exception of primary care review (11/62 
geriatricians vs 20/54 non-geriatricians; p=0.02); falls prevention programmes were reported by 
13/62 geriatricians and 19/54 non-geriatricians (p=0.09) 
 
Discussion 
Main findings 
From the frailty perspective, a high proportion of respondents from hospital settings reported they 
identify frailty on both integrated AMUs and those dedicated to the care of older people. A broad 
range of staff members are involved in identifying frailty, and similar tools were popular across 
the in-patient areas surveyed. We found that frailty identification on general medical AMUs and 
surgical areas was reported to be less common. Many respondents reported that CGA is offered as 
an intervention. When considering the components of CGA offered, rates of exercise interventions, 
medication review and delirium prevention were all lower than would be expected for a fully 
comprehensive approach, suggesting that the process of CGA may not be optimal in all cases. 
 
The community frailty element of the questionnaire revealed that a wide range of individuals are 
involved in case finding, using a variety of tools. Again, the majority reported offering CGA, but 
we found that key components, such as medication review, were often missing suggesting a less 
than comprehensive approach.  
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Less than half of those responding reported that they identified sarcopenia in their organisation; it 
is also probable that respondents are more likely to diagnose sarcopenia given the nature of the 
group targeted by the survey. Despite this, very few respondents made the diagnosis of sarcopenia 
using a recognised algorithm, and some respondents relied on questions or history rather than 
objective measures of muscle mass and function. These findings suggest that the label of 
sarcopenia is being applied without an accurate diagnostic workup. The responses also indicated 
that resistance-based exercise programmes - the only intervention with proven efficacy in 
sarcopenia – were not routinely offered, suggesting that current therapeutic approaches are not 
aligned with the available evidence.  
 
Two surveys of practice performed recently merit comparison with our results; both allude to the 
management of frailty rather than sarcopenia. The UK-based Hospital Wide Comprehensive 
Geriatric Assessment (HoW-CGA) project included a survey of frailty identification that was sent 
to all acute NHS Trusts and health boards in the UK.14 60/175 organisations returned a 
questionnaire; a similar variety of tools was used to identify people with frailty, with the Edmonton 
Frail Scale and timed-up-and-go test being the most commonly reported. Components of 
assessment performed for those found to be frail were variable; cognitive assessment, mobility and 
falls risk, pain, medication record and skin integrity were assessed in >90% of services, but sensory 
loss and depression were sought in <70% of services. 
 
An international survey of 388 clinicians (88% of whom were geriatricians, mostly from Europe) 
found that similar to our results, gait speed, the Rockwood CFS, the short physical performance 
battery, and the Fried phenotypic criteria were the most commonly used diagnostic tools for frailty, 
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being used by >25% of respondents in each case.15 Reasons given for assessing frailty included 
prognostic purposes, to aid decision-making, and because it was recommended by guidelines, with 
a combination of these factors being the most common reason. Lack of time and lack of appropriate 
tools were cited as barriers by respondents. The survey did not attempt to collect information on 
what aspects of management were offered to people with frailty. 
 
 
Strengths and limitations 
Our survey had several strengths. Our enquiries into current practice in the diagnosis and 
management of sarcopenia are novel, and our results shed important light on the management of 
frailty in the UK across several different clinical environments. The multidisciplinary nature of the 
responses to our survey is also a strength. A number of limitations also require comment. Survey 
response rates are never optimal, and so cannot provide us with a complete picture of practice 
across the UK. In particular, response rates to the sarcopenia element of the survey were low, 
perhaps in keeping with the lower clinical profile that sarcopenia currently enjoys compared to 
frailty. Additionally, the responses received will be subject to responder bias i.e. organisations 
responding to the survey will be those that are more likely to identify sarcopenia and frailty. 
  
In terms of hospital practice, we received responses from between one half and one quarter of NHS 
trusts and NHS Boards in the UK. Within these responses, we have relied on individuals’ 
knowledge and perspective of the service provided within their organisation, and that perspective 
may differ between individuals in the same organisation. In the community part of the survey, the 
respondents were mainly geriatricians. As the vast majority of clinical activity around frailty in 
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the community setting will be led by GPs, it is unlikely that we have gained a full picture of how 
frailty is identified and managed in the community setting, and practice is likely to be different in 
areas without geriatrician involvement. Response rates to the sarcopenia questionnaire were lower 
than for the frailty questionnaires, and this may reflect the lower profile of sarcopenia in clinical 
practice compared to frailty. 
 
Implications for clinical practice and research 
Several lessons for practice and research can be drawn from these results. Firstly, it is reassuring 
to see that frailty identification has engaged a wide range of professional groups – this is to be 
celebrated and augurs well for the delivery of responsive, accessible services. Less optimistically, 
a very wide range of tools are being used to diagnose frailty, and this is a barrier to comparisons 
across or within organisations. Use of a standard tool to screen for, and to diagnose frailty, would 
facilitate training, communication between teams, audit and benchmarking, but would also enable 
research studies to be designed using the same tool as was used in clinical practice – thus enabling 
findings to be translated more easily into practice. Similar issues surround the identification of 
sarcopenia; attention needs to be paid to promotion of standard diagnostic criteria, provision of 
equipment and training to allow measurement of muscle mass in routine practice. The recently 
revised EWGSOP criteria for diagnosing sarcopenia have been simplified somewhat, in 
acknowledgement of the challenges of making the diagnosis in clinical practice; whilst muscle 
mass measurement is still recommended, a diagnosis of ‘probable sarcopenia’ can now be made 
on measures of strength alone.22  
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A ‘know-do’ gap exists in the management of frailty and sarcopenia. For both conditions, exercise 
training is known to be effective, and yet patients with frailty or sarcopenia are not being offered 
such programmes. There is a need to develop specific, rigorously tested programmes (particularly 
based on resistance training) in a form that can be delivered at scale to those found to have 
sarcopenia or frailty. Although CGA is purportedly offered to patients living with frailty by most 
respondent organisations, the intervention appears to be less than comprehensive in many cases. 
Care is needed to ensure that patients receive all the ingredients of this complex intervention; an 
approach that pays lip service to the concept of CGA without full delivery is unlikely to yield 
benefits for patients living with frailty. 
 
Nevertheless, the fact that such a wide range of UK healthcare professionals are engaged in finding 
patients with frailty, and that a growing number are paying attention to sarcopenia, are encouraging 
developments. Research and clinical practice in these fields continues to evolve rapidly, and these 
findings exhort us to promote standardised approaches diagnostic tools and management 
algorithms that will further facilitate clinical activity in this field. 
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Table 1. Tools used to identify sarcopenia (n=19 organisations): 
Muscle mass (%) 
Bioimpedance assessment 2 (11) 
Dual X-ray absorptiometry 3 (16) 
Computed tomography 2 (11) 
Magnetic resonance imaging 1 (5) 
Observation or anthropometry (%) 7 (37) 
Muscle function (%) 
Walk speed 16 (84) 
Grip strength 10 (53) 
Questionnaire / history (%)  3 (16) 
   
Number measuring muscle mass (%) 4 (21) 
Number measuring muscle function (%) 18 (95) 
Number measuring muscle mass AND muscle function (%) 4 (21) 
 
 
 
 
 
  
16 
 
Table 2: Tools currently being used to identify frailty 
 Integrated AMU 
(n=45) 
Geriatric AMU 
(n=16) 
General AMU 
(n=10) 
Community 
(n=67) 
Orthopaedic units 
(n=77) 
Other surgical units 
(n=41) 
Electronic frailty index 6 (13) 1 (6) 0 (0) 21 (31) 5 (6) 2 (5) 
Rockwood CFS 15 (33) 7 (44) 3 (30) 31 (46) 23 (30) 17 (41) 
Timed up and go 2 (4) 2 (13) 1 (10) 16 (24) 9 (12) 5 (12) 
PRISMA-7 1 (2) 1 (6) 0 (0) 7 (10) 2 (3) 1 (2) 
Edmonton Frail Scale 4 (9) 0 (0) 0 (0) 8 (12) 9 (12) 6 (15) 
One or more frailty syndromes 15 (33) 8 (50) 3 (30) 19 (28) 31 (40) 12 (29) 
Gait speed 2 (4) 1 (6) 0 (0) 11 (16) 1 (1) 1 (2) 
Frailty index from CGA 0 (0) 0 (0) 0 (0) 8 (12) 1 (1) 0 (0) 
Grip strength 0 (0) 0 (0) 0 (0) 4 (6) 4 (5) 3 (7) 
ISAR tool 0 (0) 0 (0) 0 (0) 0 (0) 1 (1) 0 (0) 
No tool 5 (11) 2 (13) 0 (0) 2 (3) 22 (29) 9 (22) 
Fried frailty score 1 (2) 1 (6) 0 (0) 4 (6) 3 (4) 2 (5) 
Other 8 (18) 6 (38) 3 (30) 1 (1) 4 (5) 5 (12) 
Don’t know 0 (0) 0 (0) 0 (0) 0 (0) 1 (1) 1 (2) 
N=number of organisations responding. CGA: Comprehensive Geriatric Assessment. CFS: Clinical Frailty Scale. ISAR: Identification of 
Seniors at Risk. PRISMA: Program of Research on Integrations of Services for the Maintenance of Autonomy 
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Table 3: Staff involved in frailty case-finding 
 Integrated 
AMU (n=45) 
Geriatric AMU 
(n=17) 
General AMU 
(n=10) 
Orthopaedic 
units (n=77) 
Other surgical units 
(n=41) 
Consultant Geriatricians 21 (47) 11 (65) 2 (20) 51 (66) 25 (61) 
Specialty Consultants* 17 (38) 1 (6) 1 (10) 5 (6) 3 (7) 
Non-consultant career grade 5 (11) 1 (6) 1 (10) 18 (24) 7 (17) 
Junior doctors 15 (33) 8 (47) 2 (20) 19 (25) 14 (34) 
Specialist nurses in geriatrics 16 (36) 9 (53) 2 (20) 9 (12) 14 (34) 
Advanced nurse practitioners 14 (31) 6 (35) 3 (30) 10 (13) 8 (20) 
AMU nursing staff 15 (33) 3 (18) 2 (20) 17 (22) 6 (15) 
Physiotherapy 18 (40) 8 (47) 5 (50) 20 (26) 16 (39) 
Occupational therapy 18 (40) 9 (53) 5 (50) 19 (25) 16 (39) 
Therapy assistants 7 (16) 0 (0) 0 (0) 7 (10) 5 (12) 
Dietitians 0 (0) 1 (6) 1 (10) 1 (1) 3 (7) 
Care assistants 2 (4) 1 (6) 0 (0) 2 (3) 0 (0) 
Not sure 1 (2) 0 (0) 0 (0) 1 (1) 0 (0) 
Other 4 (9) 2 (12) 1 (10) 4 (5) 2 (5) 
*Acute physicians on AMU; surgeons on orthopaedic or non-orthopaedic surgical wards. AMU: Acute medical unit 
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Figure 1: Interventions for people found to have frailty 
 
 
CGA: Comprehensive geriatric assessment. O/P: Outpatients. AMU: Acute medical unit  
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Supplementary Table 1: Profession of respondents to the three frailty questionnaires 
 Acute medical unit 
questionnaire 
Community questionnaire Orthopaedic and surgical 
questionnaire 
Consultant geriatrician 35 53 103 
General practitioner 0 14 2 
Non-consultant career grade 1 6 12 
Trainee geriatrician 14 4 15 
Nurse practitioner (older people specialist) 20 15 0 
Specialist nurse (surgical) - - 6 
District nurse - 1 - 
Allied health professional 16 18 23 
Manager 3 2 3 
Consultant Surgeon - - 2 
Consultant anaesthetist - - 4 
Consultant acute physician 1 - - 
Other 8 3 3 
Not stated 0 1 5 
 
 
